Salarius Pharmaceuticals, Inc. (SLRX) Total Assets by Year
Salarius Pharmaceuticals, Inc. closed fiscal year 2025 with $11.1M in total assets, $5.2M in total liabilities and $5.9M in shareholder equity. This represents an increase of 265.8% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Salarius Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SLRX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.1M+265.8% | $3.0M-54.1% | $6.6M-55.0% | $14.7M-64.1% | $40.8M+63.8% | $24.9M+79.4% | $13.9M+110.1% | $6.6M-81.1% | $35.0M-44.6% | $63.2M-33.5% | $95.1M |
| Total Liabilities | $5.2M+241.9% | $1.5M+16.3% | $1.3M-69.5% | $4.3M+102.1% | $2.1M-23.9% | $2.8M-16.3% | $3.3M-58.0% | $7.9M-79.2% | $37.9M+872.2% | $3.9M+35.5% | $2.9M |
| Total Equity | $5.9M+289.6% | $1.5M-71.4% | $5.3M-49.1% | $10.4M-73.2% | $38.7M+74.7% | $22.2M+109.4% | $10.6M+932.4% | -$1.3M+56.2% | -$2.9M-104.9% | $59.3M-35.7% | $92.2M |
SLRX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.4M+260.1% | $11.1M+265.8% | $6.1M+58.0% | $1.4M-60.8% | $2.3M-52.1% | $3.0M-54.1% | $3.9M-54.1% | $3.6M-70.5% | $4.9M-51.4% | $6.6M-55.0% | $8.4M-57.4% | $12.1M-64.2% |
| Total Liabilities | $4.5M+99.6% | $5.2M+241.9% | $1.8M+97.8% | $2.2M+88.6% | $2.3M+84.5% | $1.5M+16.3% | $935K-59.7% | $1.2M-67.6% | $1.2M-72.6% | $1.3M-69.5% | $2.3M-25.4% | $3.6M+31.5% |
| Total Equity | $3.9M+6167.4% | $5.9M+289.6% | $4.2M+45.3% | -$830K-134.9% | $62K-98.3% | $1.5M-71.4% | $2.9M-51.9% | $2.4M-71.8% | $3.6M-34.3% | $5.3M-49.1% | $6.1M-63.4% | $8.4M-72.8% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Salarius Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Salarius Pharmaceuticals, Inc.'s total assets in fiscal year 2025?
Salarius Pharmaceuticals, Inc. closed fiscal year 2025 with $11.1M in total assets, $5.2M in total liabilities and $5.9M in shareholder equity.
How fast is Salarius Pharmaceuticals, Inc.'s total assets growing?
Salarius Pharmaceuticals, Inc. (SLRX) total assets rose by 265.8% year over year, from $3.0M to $11.1M in fiscal year 2025.
How has Salarius Pharmaceuticals, Inc.'s total assets changed over the years?
Across the 11 fiscal years this page covers, Salarius Pharmaceuticals, Inc. (SLRX) total assets went from $95.1M in fiscal year 2015 to $11.1M in fiscal year 2025.
What was Salarius Pharmaceuticals, Inc.'s total assets in the most recent quarter?
Salarius Pharmaceuticals, Inc. (SLRX) reported $8.4M in total assets in Q1 2026. This represents an increase of 260.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Salarius Pharmaceuticals, Inc. (SLRX) reported on that line in every period on record.